Clinical trial

Rapalogues for Autism Phenotype in TSC: A Feasibility Study

NCT01929642

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-01

PhasePHASE2

Study timeline

Study start (unknown)2013-07-01Date precision: month

Registry last updated2021-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberous Sclerosis Complexunresolved

Self-injuryunresolved

Autismunresolved

Interventions

SirolimusDRUG · verified · RxNorm: sirolimus

EverolimusDRUG · verified · RxNorm: everolimus

Sponsors & collaborators

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.lead sponsor

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01929642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.